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RESEARCH NOTE
Feasibility of salivary cortisol collection 
in patients and companions attending dementia 
diagnostic meetings in memory clinics
H. Pavlickova1, A. E. Russell1, S. Lightman2 and R. McCabe3* 
Abstract 
Objectives: Receiving a diagnosis of dementia is life-changing for the individual and their companion. The aim of 
the study was to explore the feasibility of collecting salivary cortisol from patients who are informed if they have 
dementia and their companions. Patients and companions collected nine saliva samples in three batches: 1–2 weeks 
before, immediately before, and immediately after the diagnostic meeting. Each batch consisted of three samples 
taken in the evening, after awaking and 30 mins post-waking.
Results: 22.7% (N = 10) of 44 invited patients and nine companions agreed, with 18.2% patients (N = 8) and 15.9% 
companions (N = 7) providing samples. Participants found that saliva collection was demanding and disrupted 
routines. On a purely descriptive level, some indications of an increased cortisol stress response in patients diagnosed 
with dementia were found in this very small sample. Researchers should expect low recruitment rates in this elderly 
population. Simpler collection procedures, e.g. pre-labelled packages with date/time, possible omission of morning 
samples and objective rather than self-report assessment of waking and saliva collection times—using actigraphy 
wrist-watches bleeps to prompt people at the timepoints and electronic track caps—might improve adherence and 
improve the accuracy of timepoints when swabs were actually collected.
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Introduction
Receiving a diagnosis of dementia is life changing for 
patients and their companions. It involves facing progres-
sive cognitive and physical symptoms, concerns about 
legal issues (e.g. power of attorney) and living arrange-
ments, in particular considering moving into a care home 
away from family. Dementia is highly stigmatised and is 
the most feared illness among over 55 s [1].
One way of investigating the impact of a dementia 
diagnosis is measuring the hormone cortisol implicated 
in the bodily response to stress [2, 3]. Cortisol is most 
commonly assessed from saliva due to its non-invasive-
ness and laboratory independence. This requires par-
ticipants’ compliance with collection protocols including 
repeated sampling, and refraining from smoking, eating, 
or brushing teeth to prevent saliva contamination.
Previous literature has examined the role of cortisol in 
cognitive decline and dementia [4–6] and as a marker of 
stress in carers of individuals with dementia [7]. How-
ever, to our knowledge, no study has measured cortisol 
when receiving a diagnosis of dementia or other life-lim-
iting conditions.
While understanding the impact of the diagnosis on a 
physiological level might be informative, adhering to a 
strict saliva collection protocol might be challenging in 
this population who present with memory impairment 
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and others rely on considerable support from spouses or 
other family members/friends who may also be elderly 
and have their own healthcare needs. Asking patients 
and companions to collect saliva samples in this situation 
might present additional challenges.
Hence, the aim of the study was to examine the fea-
sibility [8] of collecting saliva samples before and after 
attending a diagnostic feedback meeting in the memory 
clinic where the patient is informed if they have dementia 





The study was part of a NIHR-funded project ‘Shared 
decision making in mild to moderate dementia (ShareD)’ 
examining patient involvement in shared decision mak-
ing in diagnostic meetings in memory clinics. The meet-
ing was to inform patients if they had dementia or not. 
The study was conducted across nine memory clinics in 
two U.K. locations—London and Devon—with ethical 
approval from Camden and Islington Research Ethics 
Committee (13/LO/1309).
Recruitment
A subsample of participants, i.e., patients and their com-
panions (relatives/friends), with a scheduled diagnostic 
feedback meeting were invited to collect saliva samples. 
Having a companion was not necessary for participation. 
The only exclusion criteria were: needing an interpreter 
or if companions were paid. Recruitment took place from 
01/03/2017 to 28/04/2017.
Patients were sent a letter by the researcher and con-
tacted by phone several weeks before their memory clinic 
meeting. The researcher visited interested patients and 
companions at home to provide detailed information, 
obtain informed consent and provide saliva collection 
instructions.
Saliva collection
Patients and companions each received nine pre-labelled 
tubes and cotton swabs to collect saliva samples. Par-
ticipants were asked to place a cotton swab under their 
tongue for 2 min. Saliva samples were collected in three 
batches taken in the evening, the following morning on 
waking, and 30 min thereafter. The first batch of samples 
was collected 1–2 weeks before the diagnostic feedback 
meeting (i.e. baseline); the second batch was collected on 
the night before and the morning of the diagnostic meet-
ing; and the third batch on the night of and morning after 
the diagnostic meeting.
The researcher explained the procedures to par-
ticipants and provided detailed written instructions. 
Patients/companions were asked if they wanted reminder 
calls: one pair wanted reminder calls. The tubes had 
barcode labels with the timepoint (baseline, night 
before clinic, night after clinic) and time of day (even-
ing, wakeup, 30 min after wakening) when saliva was to 
be collected. All nine samples were collected together 
by the researcher and participants reimbursed with £20. 
Adherence to the instructions were assessed in  based 
on researcher interviews with the patients/companions 
when collecting the samples.
Participants were instructed to refrain from smoking, 
eating, or brushing their teeth for at least 30 min before, 
and consuming alcohol for 12 h before cortisol collection. 
They were asked to store samples in their home freezer.
Participants’ reports regarding the feasibility of self-
collection of saliva samples around diagnostic meetings 
at memory clinics were analysed descriptively.
Saliva samples were stored in accordance with Human 
Tissue Act regulations in a − 80 °C freezer at the Univer-
sity of Exeter Medical School until shipped for analyses. 
Samples were frozen at − 80 °C and analysed in duplicate 
at ARU Biomarker Laboratory, Cambridge, UK. Corti-
sol levels were determined using a commercially availa-
ble competitive ELISA (Salimetrics LLC, Carlsbad, CA, 
USA). Samples were thawed, vortexed and centrifuged at 
1500×g for 15 min and clear samples pipetted into appro-
priate wells. Samples were thawed and reconstituted with 
0.125 mL of Salimetrics cortisol assay diluents. The inter-
assay variability calculated from the average CVs of high 
and low controls was 5.7% (n = 10). The intra-assay vari-
ability was calculated from the average CVs for the assay 
as 5.68% (n = 133).
Cortisol variables
Three composite indices were calculated to describe the 
diurnal cortisol profile: Diurnal cortisol slope (DCS), 
Area under the curve with respect to ground (AUC G), 
and Cortisol Awaking Response (CAR).
DCS was calculated by subtracting cortisol bedtime 
values from values immediately after waking and dividing 
by the number of hours between the two samples [9]. The 
following formula was used to calculate AUC G: number 
of hours between bedtime and wakeup samples × (cor-
tisol concentration at bedtime + cortisol concentration 
at wakeup)/2 [10]. As participants did not record the 
exact collection time of each sample, we estimated 8  h 
as a distance between samples for both DCS and AUC G 
calculations.
CAR was calculated as the ratio of the post-awakening 
sample to wakeup sample [11].
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Data analyses
Given the feasibility nature of the study and a small data 
set, cortisol levels were analysed descriptively. Normality 
tests were not performed. Statistical analyses were per-
formed in SPSS 24 and Stata 12.
Results
44 patients and their companions were invited to take 
part. Ten out of 45 patients agreed: the patient consent 
rate was 22.7%. Eight companions consented. One patient 
was living alone so had no companion to be approached. 
Eight participants (18.2%) and seven companions (15.9%) 
collected saliva samples. Participant flow is available 
from authors on request.
Participant socio‑demographic and clinical characteristics
Socio-demographic and clinical characteristics of partici-
pants and their companions who collected saliva samples 
are presented in Table 1.
Two of the eight participants completing cortisol col-
lection received a diagnosis of dementia at the memory 
clinic. Six participants did not have dementia (see Table 1 
for more detail), including two participants who were 
invited for further tests to determine the diagnosis.
Feasibility of self‑administered saliva collection in memory 
clinic patients and their companions
Reasons for  not  taking part in  cortisol collection 77.2% 
(N = 34) patients declined to participate. They gave rea-
sons including: saliva collection was too burdensome; 
feeling concerned about the memory clinic appointment; 
or being too unwell. While we could not collect systematic 
data on the characteristics of participants who declined as 
we did not have ethical approval, anecdotally they found 
the salivary collection procedures confusing.
Participant feedback on  process Participants were 
elderly and most of them were supported in saliva collec-
tion by live-in companions (i.e. spouse/child). Although 
participants were offered telephone reminders from the 
research team, all except one pair declined.
All participants provided feedback. They reported:
• Collection instructions were confusing, such as 
matching individual swabs with prelabelled tubes;
• Difficulties abstaining from alcohol. Of the eight par-
ticipants who collected saliva samples at least two 
reported drinking alcohol on the days of the swabs;
• Swabs were extremely dry in the mouth;
• Disruptions to established morning routines—wait-
ing half an hour after waking before eating/drinking/
teeth brushing—and evening routines—abstaining 
from alcohol;
• Participants with an early appointment at the mem-
ory clinic had to wake up extremely early for the two 
morning samples;
• One couple reported that they needed a mirror to see 
where the swab was in their mouth to accurately spit 
it into the tube.
Cortisol
Cortisol data cleaning Cortisol samples were excluded 
if (i) evening concentrations of cortisol were higher than 
those at awaking and/or post-awaking as this is not physi-
ologically feasible, and most likely caused by mislabelling 
or mixing up tubes (six samples); (ii) samples were of the 
same low value (seven samples). This is likely to be caused 
by collecting samples at the same time in the evening. In 
addition, two samples were treated as missing due to the 
lack of sufficient saliva for analyses. Values of 1.0 nmol/L 
were assigned to three cortisol samples with levels below 
the minimum detectable level for the assay (1.0 nmol/L). 
Hence, not all samples obtained could be analysed: 18 
samples were not analysed either due to mixing up of 
times or lack of sufficient saliva for analysis. After data 
cleaning, there were 133 observations.
Table 1 Participant socio-demographic and  clinical 
information
Patient (N = 8)
Mean (SD or %)
Companion (N = 7)
Mean (SD or %)
Age 68.5 (13.2) 61.8 (13.33)
Sex
 Female 4 (50.0%) 4 (57.1%)
 Male 4 (50.0%) 3 (42.9%)
Marital status
 Married/partnership 5 (62.5%) 6 (85.7%)
 Single 0 (0%) 0 (0%)
 Divorced 1 (12.5%) 0 (0%)
 Widowed 2 (25.0%) 1 (14.3%)
Ethnicity
 White British 7 (87.5%) 0 (0%)
 White and Black Caribbean 1 (12.5%) 7 (100%)
Companion relationship
 Spouse 5 (62.5%)
 Daughter/son 1 (12.5%)
 Friend 2 (25.0%)
Diagnosis
 Alzheimer’s disease 2 (25.0%)
 Mild cognitive impairment 3 (37.5%)
 Anxiety or stress 1 (12.5%)
 No diagnosis—further tests 2 (25.0%)
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Cortisol levels in  patients with  and  without dementia 
and companions On a descriptive level, baseline cortisol 
levels were lower in participants diagnosed with dementia 
than those without dementia. Cortisol levels around the 
diagnostic meeting were higher in patients who received 
the diagnosis of dementia (M = 8.25, SD = 2.38), com-
pared to those who did not (M = 5.94, SD = 4.38)—see 
panels b and c in Fig. 1. In companions, there were less 
pronounced differences between the groups (in com-
panions of patients with dementia M = 7.76, SD = 1.65 
compared to companions of patients without dementia 
M = 7.56, SD = 3.73)—see panels e and f in Fig. 1.
The composite values (DCS, AUCG and CAR) support 
the above findings (Table 2). Higher DCS and AUC G val-
ues were found the night before and the night after the 
diagnostic meeting in patients who received a diagnosis 
of dementia, while CAR was decreased after the diagnos-
tic meeting. Due to the heterogeneity of non-dementia 
diagnoses (mild cognitive impairment, anxiety and no 
diagnosis) limited sample size, these findings are pre-
sented in a purely descriptive manner.
Discussion
There are significant challenges to collecting salivary cor-
tisol at home in this population. Over 75% of patients 
approached to participate in the study on cortisol in rela-
tion to diagnostic visits declined. Over 90% of consenting 
participants collected samples assisted by a family mem-
ber/friend. However, adhering to the collection proto-
col—particularly the morning samples—was challenging 
as it impacted on participants’ established routines and a 
number of samples could not be analysed.
Future studies with older adults referred to memory 
clinics investigating diagnosis related stress should be 
aware that there is likely to be a low recruitment rate 
and problems with the integrity of the samples obtained. 
Given the demands on protocol adherence in cortisol 
studies and the circumstances of this population, mini-
mising the burden on participants is important. This is 
aided by simple instructions, and pre-labelled packages, 
clearly indicating the date/time swabs are to be taken. 
Some studies might omit the morning samples: while 
they require timely collection [12], they were reported 
Fig. 1. Cortisol in patients with and without a diagnosis of dementia
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as most intrusive and difficult to complete. Another 
option might be to provide actigraphy wrist-watches 
pre-programmed with bleeps to prompt collection of 
samples. Rather than relying purely on self-report, more 
reliable data on waking and saliva collection times could 
be obtained using a combination of actigraphy wrist-
watches and electronic track caps. However, this popula-
tion may need assistance to collect reliable samples and 
to maximise the integrity of the samples.
Limitations
Precise times of saliva sample collection were not col-
lected. Further limitations include lack of documenta-
tion of awakening time and possible delays in sampling 
which may not have captured the CAR, along with esti-
mating 8 h between bedtime and wakeup samples. More-
over, subjective measures of participant stress were not 
administered due to additional participant burden. As 
participants who needed an interpreter could not par-
ticipate, the findings are limited in their generalizability 
to non-English speaking participants. Participants likely 
to receive a diagnosis of dementia are probably less likely 
to participate. Two participants were invited for further 
tests: for the present purposes, they were treated as par-
ticipants without dementia, which might have introduced 
some noise. Ideally, in a larger sample these participants 
would be treated as a distinct category.
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